PMID- 30311501 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220414 IS - 1555-3892 (Electronic) IS - 0963-6897 (Print) IS - 0963-6897 (Linking) VI - 27 IP - 11 DP - 2018 Nov TI - Exosomes Derived from IDO1-Overexpressing Rat Bone Marrow Mesenchymal Stem Cells Promote Immunotolerance of Cardiac Allografts. PG - 1657-1683 LID - 10.1177/0963689718805375 [doi] AB - BACKGROUND: The immunosuppressive activity of mesenchymal stem cells (MSCs) has been exploited to induce tolerance after organ transplantation. The indoleamine 2,3-dioxygenase (IDO) may have beneficial effects in the immunoregulatory properties of MSCs. It was recently revealed that exosomes derived from MSCs play important roles in mediating the biological functions of MSCs. This study aimed to explore the roles of exosomes derived from MSCs in the induction of immune tolerance. METHODS: Dendritic cells (DCs) and T-cells were cultured with exosomes derived from rat bone marrow MSCs (BMSCs) overexpressing IDO1 or controls. For the in-vivo study, rats received heart transplants and were treated with exosomes from IDO-BMSCs and heart function was evaluated. Flow cytometry was used to detect expression of cell surface markers. Cytokine levels were detected in culture supernatants or serum samples. Protein and microRNA expressions in exosomes were investigated by chips. RESULTS: Exosomes from IDO-BMSCs cultured with DCs and T-cells (1) downregulated CD40, CD86, CD80, MHC-II, CD45RA, CD45RA+CD45RB, OX62, and upregulated CD274 expression, (2) increased the number of regulatory T-cells (Tregs) and decreased the number of CD8+ T-cells, and (3) decreased the levels of pro-inflammatory cytokines, but increased the levels of anti-inflammatory cytokines compared with the other groups. Transplanted rats, which were injected with exosomes from IDO-BMSCs, had reduced allograft-targeting immune responses and improved cardiac allograft function. Exosomes secreted by IDO-BMSCs exhibited significant upregulations of the immunoregulatory protein FHL-1, miR-540-3p, and a downregulation of miR-338-5p. CONCLUSION: Exosomes derived from IDO-BMSCs can be used to promote immunotolerance and prolong the survival of cardiac allografts. FAU - He, Ji-Gang AU - He JG AD - Department of Cardiovascular Surgery, First People's Hospital of Yunnan Province, Kunming, Yunnan Province, China. FAU - Xie, Qiao-Li AU - Xie QL AD - Department of Cardiovascular Surgery, First People's Hospital of Yunnan Province, Kunming, Yunnan Province, China. FAU - Li, Bei-Bei AU - Li BB AD - Department of Cardiovascular Surgery, First People's Hospital of Yunnan Province, Kunming, Yunnan Province, China. FAU - Zhou, Liang AU - Zhou L AD - Department of Cardiology, First People's Hospital of Yunnan Province, Kunming, Yunnan Province, China. FAU - Yan, Dan AU - Yan D AD - Department of Intensive Care Unit, First People's Hospital of Yunnan Province, Yunnan Province, China. LA - eng PT - Journal Article DEP - 20181012 PL - United States TA - Cell Transplant JT - Cell transplantation JID - 9208854 SB - IM PMC - PMC6299201 OTO - NOTNLM OT - 3-dioxygenase OT - bone marrow mesenchymal stem cells OT - cardiac allograft OT - exosomes OT - immunotolerance OT - indoleamine 2 COIS- Declaration of Conflicting Interests: The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. EDAT- 2018/10/13 06:00 MHDA- 2018/10/13 06:01 PMCR- 2018/11/01 CRDT- 2018/10/13 06:00 PHST- 2018/10/13 06:00 [pubmed] PHST- 2018/10/13 06:01 [medline] PHST- 2018/10/13 06:00 [entrez] PHST- 2018/11/01 00:00 [pmc-release] AID - 10.1177_0963689718805375 [pii] AID - 10.1177/0963689718805375 [doi] PST - ppublish SO - Cell Transplant. 2018 Nov;27(11):1657-1683. doi: 10.1177/0963689718805375. Epub 2018 Oct 12.